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Abstract
The aim of this study was to develop a human model of acute wound healing that isolated the effects of small fiber
neuropathy on the healing process. Twenty-five healthy subjects had the transient receptor vanilloid 1 agonist capsaicin
and placebo creams topically applied to contralateral areas on the skin of the thigh for 48 hours. Subjects had shallow (1.2
millimeter) and deep (.3 millimeter) punch skin biopsies from each thigh on days 1 and 14. Biopsy wound healing was
monitored photographically until closure. Intra-epidermal and sweat-gland nerve fiber densities were measured for each
biopsy. Shallow wounds in capsaicin-treated sites healed more slowly than in placebo treated skin with biopsies taken on
day 1 (P,0.001) and day 14 (P,0.001). Deep biopsies in the capsaicin and placebo areas healed at similar rates at both time
points. Nerve fiber densities were reduced only in capsaicin treated regions (P,0.01). In conclusion, topical application of
capsaicin causes a small fiber neuropathy and is associated with a delay in healing of shallow, but not deep wounds. This
novel human model may prove valuable in the study of wound healing in patients with neuropathy.
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Introduction
Small fiber neuropathy is common in diseases such as diabetes
and leads to impaired neurogenic inflammation and wound-
healing capacity [1,2]. Damage to small sensory nerve fibers leads
to reduced axon-reflex vasodilation (mediated by nociceptive C-
fibers), which is a critical component to neurogenic inflammation
[3–5]. However, the mechanism by which dysfunction of small
sensory nerve fibers contributes to reduced wound-healing
capacity is not fully understood [6].
There are no studies in humans that specifically examine the
effect of small fiber neuropathy on wound healing. Most studies of
wound healing in animals are performed with other comorbid risk
factors [7–12]. It is widely accepted that neuropathy increases the
risk of ulcer development in humans but the specific effects of
neuropathy on wound healing are less clear. A prior study
investigating the healing of acute biopsy wounds did not find any
difference in healing rates between healthy subjects and patients
with diabetes [1], although other studies have demonstrated
delayed vascular and neural repair in humans with diabetes
[13,14]. Clinically, we have observed delayed healing of skin
biopsies in some patients with neuropathy, but this has not been
studied systematically.
In cutaneous tissue repair, re-epithelialization occurs through
migration of keratinocytes from free wound edges [15]. In partial-
thickness wounds, additional sources for keratinocytes are dermal
adnexal structures, such as hair follicles and sweat glands, which
remain in the wound bed. These adnexal structures can contribute
to nearly half of the re-epithelialization process [16–21]. This is in
contrast to deeper (full-thickness) wounds where hair and other
adnexal structures no longer remain and wound healing is
therefore delayed [16–21]. The cutaneous adnexal structures in
the dermal layer are innervated by small sensory and autonomic
nerve fibers, and damage to these nerve fibers might attenuate the
contribution of dermal structures to the wound healing process
[22–25].
We hypothesized that an injury to small sensory and autonomic
nerves in otherwise healthy individuals would delay healing of
partial but not full-thickness wounds. We theorized that disruption
of local axon-reflexes using a chemical axotomy model would
prevent stimulation of keratinocytes from adnexal structures
during tissue injury, thereby delaying wound healing. In order to
test this hypothesis, we designed a novel human model of wound
healing to study the effects of small fiber neuropathy, with and
without cutaneous adnexal structure input, on the healing process.
We topically applied the transient receptor vanilloid 1 agonist
capsaicin to the skin of healthy subjects to cause degeneration of
cutaneous nociceptive and autonomic nerve fibers [14,26,27]. We
performed partial and full-thickness skin biopsies in the capsaicin
and placebo regions at different time points to create cutaneous
wounds, monitored by high-resolution photography, to determine
the effects of a small fiber neuropathy on wound healing rates.
Methods
Subjects
Twenty-seven healthy subjects were recruited for the study.
Subjects were excluded from participation if they had evidence by
history or exam of neuropathy, peripheral vascular disease, a
history of medical disease, current use of medications (except oral
contraceptives), tobacco or excessive alcohol use.
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48-hour Capsaicin Protocol
After screening, all subjects had an occlusive bandage contain-
ing 2.4 g of 0.1% capsaicin cream (Chattem Inc., Chattanooga,
TN) or placebo cream (Johnson & Johnson, New Brunswick, NJ)
applied to a 464 inch region of skin. Capsaicin and placebo
creams were applied to corresponding areas on the mid-anterior
thigh of opposite legs. Subjects were selected by block random-
ization to have placebo cream applied to one thigh and capsaicin
cream to the other. The bandages remained on the skin for 24
hours with reapplication of both capsaicin and placebo on day 2
for another 24 hours [14,27].
Testing Protocol
After removal of the capsaicin and placebo creams, subjects
underwent quantitative sensory testing, laser-Doppler flowmetry
and quantitative sudomotor axon reflex testing within the
demarcated area of both legs. Subjects then underwent two 3-
mm punch skin biopsies (partial-thickness (shallow) and full-
thickness (deep)) in the capsaicin and placebo treated areas
respectively (defined as the day 1 biopsies). Two weeks later,
subjects had another shallow and deep 3-mm punch skin biopsy
taken adjacent to the original biopsies (defined as day 14 biopsies),
totaling 8 biopsies per participant. Each biopsy site was monitored
with high-resolution digital images 3 days per week to record
healing rate until complete wound closure. All tests were repeated
on days 7, 14, 21 and 28 after removal of capsaicin/placebo
creams.
Biopsy Protocol
Punch skin biopsies (3-mm diameter) were obtained after local
anesthesia using 0.2 ml of 2% lidocaine with epinephrine
(1:10,000, Hospira, Inc., Lake Forest, IL). Shallow and deep skin
biopsies were taken from each site. A shallow (partial-thickness)
punch skin biopsy, 0.9–1.5 millimeters deep, was obtained leaving
residual dermal structures in the wound bed. Shallow biopsies
were performed by allowing the punch biopsy tool to enter only 1–
1.5 millimeters into the skin, followed by tissue removal using a
scalpel running parallel to the epidermis. A deep (full-thickness)
biopsy, 3.2–4.6 millimeters deep, was acquired using a punch
biopsy depth of 4 millimeters with removal of all dermal structures
within the biopsy area (Figure 1). The biopsy specimens served as
the tissue source for structural analysis and the remaining wounds
were monitored for healing.
Skin Biopsy Analysis
Biopsy specimens were fixed in Zambonis solution, sectioned
into 50 micrometer thick frozen sections and stained with protein
gene product 9.5 (1:1000, rabbit anti-PGP 9.5, CHEMICON
International, Inc., Temecula, CA) as previously described
[24,28]. Biopsy depth was measured in all sectioned tissue. For
all biopsies, intra-epidermal nerve fiber density (IENFD) was
quantified by a physician blinded to treatment allocation and
results were expressed as a linear density (number of fibers per
millimeter) as previously described [28,29]. Sweat gland nerve
fiber density (SGNFD) was quantified using a manual unbiased
stereologic technique as previously reported [22,24]. Briefly, a
microscope with a 6.2 megapixel camera (PixeLINK, Ontario,
Canada) was used to image tissue sections at 206 magnification
and pictures were transferred to Image Pro-Plus (Version 6.0,
Media Cybernetics, Bethesda, MD). A standardized grid of circles
(10 mm in diameter, spaced 50 mm apart horizontally, and offset
25 mm vertically) was placed over the sweat gland image. The
number of nerve fibers intersecting the circles within the area of
interest was counted. Results are reported as the percentage of
total circles with nerve fiber crossing [22,24].
Wound Healing
Biopsy wound pictures were recorded with an 8.2 megapixel
Canon EOS 30D (with attachment of a 100-mm Canon macro
lens for magnification and a MR-14EX Canon Ring Lite for
illumination; Canon USA Inc, Lake Success, NY). Images of each
biopsy were taken 3 days per week (Monday, Wednesday, Friday)
starting with the day of the biopsy. Each wound image contained a
ruler as an internal standard (Figure 2). The area of the wound was
measured by tracing the edge of the biopsy in Image Pro-Plus
(Version 6.0, Media Cybernetics, Bethesda, MD) in triplicate by
technicians blinded to treatment. The average result was reported;
if variance in measurements exceeded 10%, the image tracing was
repeated. Healing was defined as complete re-epithelialization or
loss of the wound scab.
Quantitative Sensory Testing
Testing included cold, heat, cold-pain and heat-pain perception
thresholds at each visit. Testing was performed with ascending
(heat) or descending (cold) methods of limits using standard
protocols [30]. Thermal stimuli were applied using a 16616 mm
thermode (TSA II Neurosensory Analyzer, Medoc Ltd., Israel).
The results of 4 individual trials for heat and cold, and 3 individual
trials for heat-pain and cold-pain were averaged. Subject
instructions were standardized with cueing cards. A temperature
maximum of 52uC was set to prevent thermal injury [30].
Quantitative Sudomotor Axon Reflex Testing
Quantitative sudomotor axon reflex testing was performed
following the standard protocol with iontophoresis of acetylcholine
solution (10% in sterile water) into the skin at 2 mA for 5 minutes
[31]. Recordings were analyzed by area under the curve (AUC) for
the first 15 minutes after iontophoresis.
Laser-Doppler Flowmetry
The C-fiber mediated axon-reflex was measured using the laser-
Doppler flowmetry technique after acetylcholine iontophoresis
using standard protocols [32]. C-fiber mediated vasodilation was
provoked by acetylcholine (Penta, Fairfield, NJ; 1% in sterile
water) using anodal current of 0.4 mA for 140 seconds. The
Periflux System 5000 laser-Doppler flowmeter (Perimed, Jarfalla,
Sweden) using an 8-laser integrating probe measured cutaneous
blood flow [32]. The percent change from baseline in response to
acetylcholine iontophoresis was reported. Tests were performed at
ambient room temperatures between 23.7uC and 25.6uC.
Statistical Analysis
Data are presented as mean 6 standard deviation. For the
primary analysis, time (in days) to wound closure for capsaicin and
placebo treated skin was analyzed by paired t-test, for shallow and
deep wounds respectively. Survival curves were plotted to
represent wound healing time, with survival defined as the period
from biopsy to wound closure. Repeated measures ANOVA and
post-hoc pairwise analysis with Bonferonni correction was
performed for quantitative sensory testing, quantitative sweat
testing and laser-Doppler flowmetry. Nerve fiber densities were
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define statistical significance for all data sets, with all results
compared to placebo. Statistical data analysis was performed using
SPSS v16.0 (IBM, Chicago, IL).
Results
Demographics
Twenty-five of 27 subjects completed the testing protocol. Two
subjects withdrew prior to wound closure; their results are not
included in the final analysis (data were within the range of all
other subjects at the time of withdrawal; no complications were
noted). The 25 healthy subjects who finished the study were aged
20–38 years with a mean age of 28.7 years. Eighteen of the
subjects were female. Shallow (partial-thickness) skin biopsies had
an average depth of 1.2 mm (60.3 mm). Deep (full-thickness)
biopsies had an average depth of 3.9 mm (60.7 mm).
Wound Healing
For day 1 biopsies, healing rates of shallow wounds in capsaicin
treated sites were significantly delayed compared to placebo
treated sites (24.462.7 days capsaicin vs. 17.562.8 days placebo,
P,0.001; Figure 2). Deep biopsy wounds in the capsaicin and
placebo areas healed at similar rates (25.163.8 days capsaicin vs.
24.263.3 days placebo, P=0.43; Figure 2). For day 14 biopsies,
healing rates of shallow wounds in capsaicin treated sites were
significantly delayed compared to placebo treated sites (22.463.1
days capsaicin vs. 17.662.8 days placebo, P,0.001; Figure 2).
Day 14 deep wounds in the capsaicin and placebo areas healed at
similar rates (25.663.8 days capsaicin vs. 23.563.4 days placebo;
P=0.09; Figure 2). Shallow wounds healed more quickly on day
14 than on day 1 from capsaicin treated regions (P=0.03; Figure 2)
No differences in gender or location were noted in wound healing
rates within groups.
Nerve Fiber Density
In biopsy specimens obtained on day 1 from capsaicin treated
areas, intra-epidermal nerve fiber density was significantly reduced
compared to placebo (0.460.6 fibers/mm capsaicin vs. 15.767.3
fibers/mm placebo, P,0.001: Figure 3). In biopsies taken on day
14 from the capsaicin treated areas, intra-epidermal nerve fiber
density was higher compared to day 1 but still reduced compared
to placebo (3.063.6 fibers/mm capsaicin vs. 15.265.8 fibers/mm
placebo, P,0.001: Figure 3). No difference was noted between
intra-epidermal nerve fiber density from shallow and deep skin
biopsies.
The sweat gland nerve fiber density was similar between deep
(full thickness) biopsies from capsaicin and placebo treated sites on
day 1 (46.3614.9 intercept density capsaicin vs. 52.0610.6
intercept density placebo, P=0.68: Figure 3). The sweat gland
nerve fiber density was reduced in deep biopsies from capsaicin
treated areas on day 14 (26.7612.8 intercept density capsaicin vs.
50.769.6 intercept density placebo, P,0.01: Figure 3). Sweat
glands were not found within shallow (partial-thickness) biopsies.
Tests of Nerve Fiber Function
In the capsaicin treated skin, detection thresholds were lower for
cold, higher for heat and higher for heat-pain on all testing days
compared to placebo treated skin (1, 7, 14, 21 and 28; P,0.01;
Figure 4a–d). Cold-pain detection thresholds were not significantly
different between groups (P=0.28). There was a decrease in the
nociceptive axon-reflex mediated response to acetylcholine ionto-
phoresis in capsaicin treated skin as measured by laser-Doppler
flowmetry on test days 1, 7, 14 and 21 (P,0.05; Figure 4e). There
Figure 1. Skin biopsies as a model of wound healing. Three millimeter punch skin biopsies from the thigh with a ruler used as an internal
standard measurement. The shallow biopsy (shown in subset) on the right contains pieces of hair follicles seen within the wound bed. The deep
biopsy (shown in subset) is on the left and contains no remnants of adnexal structures within the wound bed.
doi:10.1371/journal.pone.0054760.g001
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try on day 28 between capsaicin and placebo groups. There was a
reduction in sweat output in capsaicin treated compared to
placebo treated skin on day 7, day 14, day 21 and day 28, but not
day 1 (P,0.01; Figure 4f).
Conclusions
In this study, we report a novel human model of acute wound
healing. We, and others, have previously shown that topical
application of the TRPV1 agonist capsaicin causes both structural
and functional changes to cutaneous sensory and autonomic nerve
fibers [14,27]. In the current investigation, we demonstrate that
topical application of capsaicin, resulting in a small fiber
neuropathy, delays healing of partial-thickness wounds by more
than 30% compared to wounds in normal skin. However, no delay
in healing occurs in deeper wounds with adnexal structures
removed.
After 48 hour occlusive capsaicin treatment, there was near-
complete loss of intra-epidermal nerve fibers and reduction in
sweat gland nerve fiber density with functional changes to
quantitative sensory testing, quantitative sudomotor testing and
axon-reflex vasodilation, consistent with several prior studies
[14,27]. We found that shallow wounds taken 1 day after capsaicin
application heal at the same rate as full-thickness wounds that have
all adnexal structures removed. Shallow biopsies taken 14 days
after capsaicin treatment also healed more slowly than placebo
biopsies, thus demonstrating that the delay in wound healing from
day 1 biopsies is not solely a consequence of local neuropeptide
depletion or a transient effect of capsaicin pre-treatment on local
signaling or cellular migration [33]. Capsaicin pretreatment had
no effect on full-thickness wound healing rates and results did not
differ from placebo.
A number of possible mechanisms for the delayed wound
healing seen in our capsaicin treated biopsies are suggested by
animal studies. After cutaneous injury, recruited keratinocytes
migrate from the wound edges into the wound bed while
keratinocytes in adnexal structures contribute to nearly half of
the re-epithelialization area in partial thickness wounds [16].
Animal studies have also shown a delay in wound healing when
Figure 2. Rates of shallow and deep wound healing from capsaicin and placebo treated skin. Wound healing from day 1 (a & b) and day
14 (c & d) biopsies. Survival curves (a & c) are defined as the time from biopsy to wound closure (percent of biopsies not healed). The area of the open
wound at each time point by biopsy type and treatment is shown for day 1 (b) and day 14 (d). Shallow biopsies from capsaicin treated areas healed
more slowly than shallow biopsies from placebo treated areas (P,0.001 vs. placebo) on day 1 and day 14. There were no differences in capsaicin and
placebo treated deep biopsies (P=0.43 vs. placebo, day 1; P=0.09 vs. placebo day 14). Shallow biopsies from capsaicin treated areas healed more
quickly on day 14 (d) than on day 1 (b) (P=0.03). Statistical significance is not displayed in these graphs.
doi:10.1371/journal.pone.0054760.g002
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demonstrated that capsaicin denervation impairs hair follicle stem
cell migration leading to delays in wound healing [35]. These
results are consistent with our findings where full thickness biopsies
heal more slowly than partial thickness biopsies from placebo
treated skin that still contain adnexal structures in the wound bed.
A recent study of the effects of both chemical and excisional
axotomy demonstrates that vascular regrowth after tissue injury
precedes axonal regrowth [13]. In addition, delayed vascular
regrowth is seen in patients with diabetes. Our study compared
placebo and capsaicin treated sites within the same individual to
avoid confounding differences in baseline vascular density on
wound healing. Our functional data (sweat, sensory and axon-
reflex vasodilation) suggest that capsaicin denervation effectively
disrupts the neurogenic axon reflex. However, we cannot
distinguish the neurovascular effects on wound healing from the
neural effects on other dermal appendages using the capsaicin
model. Nonetheless, our data strongly suggest that neuropathy
may predispose to delayed cutaneous tissue repair. Although we
did not identify the mechanism of delayed healing in our study, a
recent report using chemical axotomy in rats supports our theory
that impaired stem cell migration from dermal adnexal structures
may be secondary to disruption of local neural reflexes [35].
There are several limitations to our study. Capsaicin acts widely
across many cell types that possess TRPV1 receptors. Although
capsaicin is not known to cause damage to endothelial progenitor
cells, it is possible that the application of capsaicin does reduce
progenitor cell migration, nerve signaling or other actions involved
in wound healing. Capsaicin may also alter keratinocyte prolifer-
ation and this study is unable to distinguish acute capsaicin effects
on healing from neuropathy specific effects, although we would
expect deep biopsies from capsaicin treated regions to heal more
slowly if there was a significant effect on keratinocyte proliferation
or migration. However, shallow skin biopsies taken 2 weeks after
capsaicin application still showed delayed wound healing, a finding
that cannot be explained by transient effects of capsaicin. The
evidence of neural regrowth on day 14, seen by increasing
numbers of intra-epidermal nerve fibers, demonstrate that the
acute effects of capsaicin have resolved. Another limitation is that
topical capsaicin does not penetrate deeply into the dermal layer.
Figure 3. The intra-epidermal and sweat gland nerve fiber density in capsaicin and placebo treated skin. (a) The intra-epidermal nerve
fiber density from biopsies taken on day 1 and 14 is shown (mean 6 SD). *P,0.001 compared to control. (b) The sweat gland nerve fiber density from
biopsies taken on day 1 and 14 is shown (mean 6 SD). *P,0.01 compared to control. (c, e) Protein gene product 9.5 labeled intra-epidermal nerve
fibers from day 14 biopsies in placebo (c) and capsaicin (d) treated skin. Black arrows denote intra-epidermal fibers in placebo treated skin (c), but are
not seen in capsaicin treated skin (e). (d, f) Protein gene product 9.5 labeled sweat gland nerve fibers from day 14 biopsies in placebo (d) and
capsaicin (f) treated skin.
doi:10.1371/journal.pone.0054760.g003
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partial reduction of sudomotor and vasomotor fibers, but not
complete loss as seen with epidermal nerve fibers [27]. It is unclear
if the partial loss of nerve fibers in deeper tissues is secondary to
lower densities of TRPV1 channels on non-nociceptive nerve
fibers or diminished penetration of capsaicin to deeper tissues.
Most individuals with small fiber neuropathy are older while our
study included primarily younger individuals. We intentionally
chose a homogenous population to reduce the number of potential
variables to consider in the wound healing process. Additional
study of healing rates in an older population would provide
valuable information about the effects of age on healing rates.
We report a unique method that may isolate the effects of a
small nerve fiber injury on wound healing. The technique creates a
standardized nerve injury that is reproducible, transient and can
study both healthy subjects and patients with disease without any
Figure 4. Neurophysiologic testing in capsaicin and placebo treated skin. The cold (a), heat (b), cold-pain (d), and heat-pain (d) detection
thresholds are shown for each test visit for placebo (black circles) and capsaicin (open circles) treated regions. Cold detection thresholds were lower
for every test day in the capsaicin treated side. Heat and heat-pain detection thresholds were higher for every test day on the capsaicin treated side.
No significant differences were noted in cold-pain detection thresholds. Blood flow measured by laser-Doppler flowmetry is shown in (e) for placebo
(black circles) and capsaicin (open circles) treated regions. Axon-reflex mediated blood flow was reduced in the capsaicin treated region compared to
placebo treated region on all test days except day 28. Sweat volume measured by the quantitative sudomotor axon reflex test (QSART) is shown in (f).
Sweat output was reduced in the capsaicin treated region compared to the placebo treated region on all test days except day 1. AUC=area under
the curve. *P,0.05.
doi:10.1371/journal.pone.0054760.g004
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are available, but often do not reflect the human condition because
rodent models of cutaneous injury typically heal by contracture,
while humans heal by re-epithelialization. In order to accelerate
discovery of novel therapies for wound healing, and to translate
them into clinical practice, it is imperative that effective human
models exist.
Our study demonstrates that application of topical capsaicin,
with an associated small fiber neuropathy, causes a delay in
healing of shallow wounds by 30% or more, leading to healing
rates similar to those of deep wounds. The effects of topical
capsaicin on wound healing appear to last at least 2 weeks beyond
the time of application. Our study suggests that small nerve fibers
may be a relevant contributor in the pathogenesis of acute wound
healing, but only when dermal structures remain intact - a
scenario that reflects the majority of acute superficial wounds. Our
protocol includes prolonged application of capsaicin in an
occlusive dressing, a technique that increases the delivered dose
of capsaicin beyond clinical guidelines. Our findings may not
apply to the more widespread clinical use of capsaicin as clinical
trials have not reported delayed wound healing as a complication
[36–38]. Nonetheless, we suggest that capsaicin, widely advocated
for treatment of neuropathic pain, be used with caution in patients
that are at risk for or already have wound healing impairment.
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